written on 23.05.2014
Tags:
,

Leading Pfizer and AstraZeneca shareholder BlackRock wants the megamerger

TAGS: ,

Four times Pfizer has made offers to buy AstraZeneca and four times, the U.K. company has said no. But the world's largest money-management firm hopes in this case no doesn't mean no. BlackRock–which owns 8% of AstraZeneca and 6.8% of Pfizer–is encouraging discussions between the two companies, according to Bloomberg, which cited anonymous sources.

Latest Report